Worth reading
65In focus
Scored from 3 of 5 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
982000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of the 10th Series Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)
Who receives how much982,000Shares
982,000 new shares (number of shares delivered during the relevant period)
EVO FUND (allottee of the 10th Series of Stock Acquisition Rights)
The lower thin line represents the existing number of shares to which these shares will be added.
発行済株式総数
982,000 shares delivered from the beginning of the month, compared with 12,100,500 issued shares as of the end of the month preceding the relevant month (approximately 8.1%)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥114, ¥115 or ¥116. The Stock Acquisition Rights include an exercise price adjustment clause, but the lower limit of the adjustment is not disclosed.
Number of Stock Acquisition Rights
Total issued: 82,700 rights. Since the beginning of the month, 9,820 rights have been exercised, leaving 50,160 unexercised rights as of the current date.
Basis for determining the amount to be paid
The exercise price is ¥114, ¥115 or ¥116, depending on the exercise date. The closing price and average share price used as the calculation benchmarks, as well as the discount rate and premium rate, are not disclosed.
Most recent equity financing
Timing 13 February 2026 / Type Issuance through a third-party allotment of the 10th Stock Acquisition Rights (with an exercise price adjustment clause) and the 11th Stock Acquisition Rights / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of the 10th Series Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause) |
| Number of shares to be issued or disposed of | 982,000 new shares (number of shares delivered during the relevant period) |
| Intended allottee | EVO FUND (allottee of the 10th Series of Stock Acquisition Rights) |
| Dilution Rate | 982,000 shares delivered from the beginning of the month, compared with 12,100,500 issued shares as of the end of the month preceding the relevant month (approximately 8.1%) |
| Total number of issued shares | 12,100,500 shares (as of the end of the month preceding the relevant month) → Not disclosed |
| Basis for determining the amount to be paid | The exercise price is ¥114, ¥115 or ¥116, depending on the exercise date. The closing price and average share price used as the calculation benchmarks, as well as the discount rate and premium rate, are not disclosed. |
| Exercise price | ¥114, ¥115 or ¥116. The Stock Acquisition Rights include an exercise price adjustment clause, but the lower limit of the adjustment is not disclosed. |
| Number of Stock Acquisition Rights | Total issued: 82,700 rights. Since the beginning of the month, 9,820 rights have been exercised, leaving 50,160 unexercised rights as of the current date. |
| Most recent equity financing | Timing 13 February 2026 / Type Issuance through a third-party allotment of the 10th Stock Acquisition Rights (with an exercise price adjustment clause) and the 11th Stock Acquisition Rights / Amount Not disclosed |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The 10th Stock Acquisition Rights issued by the Company on 13 February 2026 were substantially exercised during the period from 1 June to 19 June 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.